PharmaSGP Holding SE (F:PSG) — Market Cap & Net Worth
Market Cap & Net Worth: PharmaSGP Holding SE (PSG)
PharmaSGP Holding SE (F:PSG) has a market capitalization of $331.56 Million (€283.60 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #14454 globally and #1448 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PharmaSGP Holding SE's stock price €28.80 by its total outstanding shares 11512500 (11.51 Million). Also see PSG asset base for a full breakdown of the balance sheet.
PharmaSGP Holding SE Market Cap History: 2020 to 2025
PharmaSGP Holding SE's market capitalization history from 2020 to 2025. Data shows change from $306.70 Million to $387.63 Million (-2.21% CAGR). Also see PharmaSGP Holding SE (PSG) cash flow conversion for how efficiently the company converts equity into cash flow.
PharmaSGP Holding SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PharmaSGP Holding SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for PharmaSGP Holding SE for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.74x
PharmaSGP Holding SE's market cap is 2.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.67x
PharmaSGP Holding SE's market cap is 16.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $306.70 Million | $63.25 Million | $10.64 Million | 4.85x | 28.82x |
| 2021 | $303.03 Million | $65.34 Million | $10.69 Million | 4.64x | 28.35x |
| 2022 | $312.48 Million | $85.82 Million | $11.95 Million | 3.64x | 26.14x |
| 2023 | $273.82 Million | $101.10 Million | $16.40 Million | 2.71x | 16.70x |
| 2024 | $325.72 Million | $118.84 Million | $19.54 Million | 2.74x | 16.67x |
Competitor Companies of PSG by Market Capitalization
Companies near PharmaSGP Holding SE in the global market cap rankings as of September 19, 2026. Review PharmaSGP Holding SE (PSG) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to PharmaSGP Holding SE by market ranking:
- Lowland Investment Co (LSE:LWI): Ranked #14445 globally with a market cap of $332.16 Million USD ( £247.34 Million GBP).
- Sarawak Plantation Bhd (KLSE:5135): Ranked #14446 globally with a market cap of $332.06 Million USD ( RM1.32 Billion MYR).
- Top Bright Holding Co Ltd (TW:8499): Ranked #14455 globally with a market cap of $331.37 Million USD ( NT$10.52 Billion TWD).
- Bell Financial Group Ltd (AU:BFG): Ranked #14456 globally with a market cap of $331.34 Million USD ( AU$468.29 Million AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #14445 | Lowland Investment Co | LSE:LWI | $332.16 Million | £185.50 |
| #14446 | Sarawak Plantation Bhd | KLSE:5135 | $332.06 Million | RM4.74 |
| #14455 | Top Bright Holding Co Ltd | TW:8499 | $331.37 Million | NT$255.50 |
| #14456 | Bell Financial Group Ltd | AU:BFG | $331.34 Million | AU$1.46 |
PharmaSGP Holding SE Historical Marketcap From 2020 to 2025
Between 2020 and today, PharmaSGP Holding SE's market cap moved from $306.70 Million to $ 387.63 Million, with a yearly change of -2.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €387.63 Million | +19.01% |
| 2024 | €325.72 Million | +18.95% |
| 2023 | €273.82 Million | -12.37% |
| 2022 | €312.48 Million | +3.12% |
| 2021 | €303.03 Million | -1.19% |
| 2020 | €306.70 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 10th, 2026 the market cap of PharmaSGP Holding SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.56 Million USD |
| MoneyControl | $331.56 Million USD |
| MarketWatch | $331.56 Million USD |
| marketcap.company | $331.56 Million USD |
| Reuters | $331.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PharmaSGP Holding SE
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil … Read more